Novel therapeutic strategies to counter Pseudomonas aeruginosa infections

Expert Review of Anti-infective Therapy
Joanne L FothergillChloe E James

Abstract

Pseudomonas aeruginosa is a highly successful opportunistic pathogen that displays intrinsic multidrug resistance and has a tremendous capacity to acquire further resistance mechanisms. During chronic infection, the bacterium can form a protective biofilm therefore reducing the efficacy of existing antibiotics. P. aeruginosa also harbors an impressive range of virulence factors, many of which are controlled by the quorum-sensing system. Several novel therapeutics are under investigation such as those directed against biofilm formation and quorum-sensing systems along with bacteriophages and immunotherapies. Recent advances in next-generation sequencing and comparative genomics have opened the door to a new wave of smart drug design that could revolutionize P. aeruginosa treatment options.

References

May 1, 1975·The American Journal of Medicine·J E PenningtonA S Levine
Apr 1, 1992·Journal of Internal Medicine·F FranzettiM Moroni
Jan 1, 1989·Free Radical Biology & Medicine·J A SimpsonR T Dean
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·W W NicholsH L Walmsley
Feb 22, 1985·JAMA : the Journal of the American Medical Association·P ThomasK Martin
Jul 1, 1966·Journal of Bacteriology·P F BartellG K Lam
Sep 1, 1995·Journal of Industrial Microbiology·A Boyd, A M Chakrabarty
Feb 1, 1996·Infection and Immunity·J M MeyerI A Holder
Jan 22, 1998·Canadian Journal of Microbiology·M Ghani, J S Soothill
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·R W HendrixG F Hatfull
Mar 18, 2000·Infection and Immunity·M HandfieldR C Levesque
Dec 6, 2000·The European Respiratory Journal·G DöringD J Touw
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·D NelsonV A Fischetti
Aug 14, 2001·Infection and Immunity·I A HolderD W Frank
Aug 22, 2001·Journal of Bacteriology·M HentzerM R Parsek
Sep 7, 2001·Annual Review of Microbiology·W C Summers
Oct 26, 2001·Nature·M WhiteleyE P Greenberg
Apr 20, 2002·Current Opinion in Infectious Diseases·Hartmut LodeHarald Mauch
May 9, 2002·British Medical Bulletin·C Anthony Hart, Craig Winstanley
May 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Iain L LamontMichael L Vasil
Jun 29, 2002·The Journal of Infectious Diseases·Dara W FrankTeiji Sawa

❮ Previous
Next ❯

Citations

Aug 22, 2012·Extremophiles : Life Under Extreme Conditions·Prashant GabaniOm V Singh
Jan 16, 2013·Antimicrobial Agents and Chemotherapy·Julia GödekeSusanne Häussler
Aug 27, 2014·Future Microbiology·Dianella Savoia
Dec 22, 2015·Journal of Inorganic Biochemistry·Biljana Đ GlišićJasmina Nikodinovic-Runic
Mar 8, 2016·Trends in Microbiology·Craig WinstanleyMichael A Brockhurst
Oct 28, 2015·The Journal of Antimicrobial Chemotherapy·Praveen PapareddyMartin Malmsten
Feb 18, 2014·BioFactors·Carlo BonchiEmanuela Frangipani
Nov 17, 2012·Microbiology·Audrey DagornMarc G J Feuilloley
Jan 16, 2013·Trends in Microbiology·Meritxell García-QuintanillaMichael J McConnell
Dec 24, 2016·Molecular Microbiology·John M Farrow, Everett C Pesci
Jun 24, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F Tagini, G Greub
Sep 19, 2014·Perspectives in Medicinal Chemistry·Richard J Fair, Yitzhak Tor
May 7, 2014·Antimicrobial Agents and Chemotherapy·Vera Lúcia Dias SiqueiraCelso Vataru Nakamura
Nov 12, 2013·MicrobiologyOpen·Anthony De SoyzaCraig Winstanley
Jul 3, 2019·Antimicrobial Agents and Chemotherapy·Michael R M RanieriLori L Burrows
Aug 15, 2017·Expert Review of Anti-infective Therapy·Alberto Enrico MaraoloIvan Gentile
Mar 18, 2021·Glycoconjugate Journal·Laura MorelliFederica Compostella
May 8, 2021·Journal of Medical Microbiology·Andris Evans, Kevin A Kavanagh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.